课题基金 / 基金详情

Targeted and immuno-therapy to overcome innate and acquired resistance in aggressive MAPK-addicted cancers.

Targeted and immuno-therapy to overcome innate and acquired resistance in aggressive MAPK-addicted cancers.
靶向和免疫治疗可克服侵袭性 MAPK 成瘾癌症的先天性和获得性耐药性。
批准号:
469037
负责人:
Nichols Anthony C
金额:
$72.17万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01

项目摘要

项目成果

Nichols Anthony C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Thyroid cancer is one of the fastest rising cancers in Canada. Most thyroid cancers are non-aggressive types and are almost always cured with surgery. In contrast, anaplastic thyroid cancer (ATC) accounts for only 1% of thyroid cancers but is perhaps the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the tumour immune microenvironment underlying chemoradiation resistance in human papillomavirus related head and neck cancer
  • 批准号:
    465385
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Nichols Anthony C
  • 依托单位:
Mechanisms of resistance to cisplatin and radiation in human papillomavirus (HPV) related head and neck cancer
  • 批准号:
    431688
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2020
  • 负责人:
    Nichols Anthony C
  • 依托单位:
The Evolution of the Most Lethal Human Malignancy: The Genetic Progression of Anaplastic Thyroid Cancer
  • 批准号:
    357705
  • 项目类别:
    Operating Grants
  • 资助金额:
    $48.15万
  • 财政年份:
    2016
  • 负责人:
    Nichols Anthony C
  • 依托单位:
Mechanisms of resistance and sensitivity to PI3K inhibition in head and neck cancer.
  • 批准号:
    320547
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.52万
  • 财政年份:
    2015
  • 负责人:
    Nichols Anthony C
  • 依托单位:
海外基金